Neuropharmacology & Neurotherapeutics
Cerebral vasospasm: treatment
Oct. 17, 2021
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
T2-weighted sagittal MRI of the cervical cord demonstrates atrophy in a 32-year-old patient with urinary retention, spastic paraparesis, and HTLV-1 detectable in the CSF. This finding has been described previously in HAM/TSP. Atrophy was found at a similar rate in the patient with multiple sclerosis the authors studied. (Used with permission from: Howard A, Li D, Oger J. MRI contributes to the differentiation between multiple sclerosis and HTLV-1 associated myelopathy in British Columbian coastal natives. Can J Neurol Sci 2003;30:41-8.)